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Abstract
Background: Published long-term outcomes of oncoplastic breast-conserving surgery are scarce and, specifically,
aesthetic outcomes assessed with an objective method have not previously been published.
Methods: A cohort of 41 patients treated with a quadrantectomny and immediate reconstruction using a
myocutaneous latissimus dorsi flap were analyzed and their aesthetic outcomes were evaluated objectively by
BCCT.core software.
Results: At the end of a 58-month follow-up from the date of initial diagnosis, one patient (2.4%) developed an
ipsilateral recurrence, six patients developed distant metastases and three patients died (7.3%) without ipsilateral
recurrence, one of them presenting hepatic metastases at the time of the initial diagnosis. We were able to
evaluate aesthetic results in 23 patients, 3 assessed as excellent, 12 good and 8 fair.
Conclusion: This oncoplastic volume replacement technique obtained a good local control and satisfactory and
stable aesthetic results which have maintained unchanged after a long period of time.
Keywords: Oncoplastic breast surgery, long-term outcomes, cosmetic outcome and latissimus dorsi flap
Background
Oncoplastic breast-conserving surgery (OBS) has
become a gold standard in the surgical treatment of
early breast cancer increasing the rate of breast conser-
ving treatment (BCT), avoiding mastectomies and cos-
metic sequelaes, and improving patients’ quality of life
and self-esteem.
Aesthetic outcome and degree of patient satisfaction is
related to the percentage of breast tissue excised so
when the preoperative estimation of this volume exceeds
20% of the total breast volume a reconstructive techni-
que is required to obtain a good cosmetic outcome
[1-3]. This option allows the achievement of the OBS
goal: complete removal of the lesion, clear margins, the
larger the better, good to excellent cosmetic result and
operating once so as to perform the definitive procedure
avoiding a complicated breast reconstruction postmas-
tectomy process [4].
We published our experience using an OBS volume
replacement technique (OVR), a real quadrantectomy
and immediate reconstruction with myocutaneous latis-
simus dorsi flap (LDF) in one-stage procedure, analyzing
the early results. The technique showed its utility allow-
ing extensive resection, extending BCT to tumors with a
mild response or no response after neoadjuvant che-
motherapy, achieving good cosmetic outcomes and, in
short, it could be particularly useful when radiotherapy
indication, in the event of a mastectomy, were present
before surgery or likely after surgery based on pathologi-
cal features, such as more than three involved lymph
nodes or bad prognostic factors [5-7]. Our experience
with this technique obtained good early cosmetic results
showing that symmetry and the quality of the recon-
structed breast scar were the most influential factors in
determining the cosmetic result [6].
The lack of randomized trial data makes comparison
of OBS techniques difficult; most studies involve small
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any medium, provided the original work is properly cited.cohorts of patients assessed for outcome in various ways
and as far as aesthetic results are concerned, these are
heterogeneous and difficult to evaluate in a standardized
way [8]. A computer system (BCCT.core) has been
developed to objectively and automatically evaluate the
aesthetic result of BCT and it is has been proposed as a
gold standard method for assessment of breast cosmesis
in clinical trials as standard [9].
Some factors can deteriorate the early aesthetic out-
come: the effect of radiotherapy reducing breast size
and increasing the fibrotic, changes in body weight, and
aging and gradual breast ptosis, which would worsen
the cosmetic result increasing breast asymmetry. This
has been experienced by Gendy, who observed an incre-
ment of the cosmetic failure rate from 10 to 18%, in a
period of 43 months, in patients treated with a partial
mastectomy with latissimus dorsi miniflap reconstruc-
tion [10].
This article aims to evaluate the long-term results,
oncologic and aesthetic, of a cohort of patients treated
with an OVR and observe the effect of time on the cos-
metic results.
Methods
We reviewed the records and radiological images of 41
patients treated with partial mastectomy (quadrantect-
omy or sector mastectomy) and immediate breast recon-
struction by LDF (one-stage procedure) from November
2002 to May 2010; the patients’ characteristics are
described in table 1.
We calculated the estimated breast volume (Vbr)o f3 3
patients based on mammogram measurements using a
modification of the Katariya method [11] assuming the
elliptical cone projection with the formula:
Vbr = 1/3piRcc Rol Hol
where (Hol)h e i g h ta n d( R ol)r a d i u sm e a s u r e m e n t s
were taken from oblique mammogram projection and
Rcc radius from craneocaudal projection.
Tumor size was defined as the largest dimension
recorded on mammogram or magnetic resonance ima-
ging (MRI); in those patients who were treated preo-
peratively with chemotherapy this measurement was
taken from the MRI or mammogram once the treatment
was finished or interrupted. The estimated volume of
resection (Vers) was determined assuming that theoreti-
cal resection is a sphere containing the tumor in its core
surrounded by 1 cm of healthy breast tissue (margin):
Vers = 4/3piR3
where R is equal tumor size/2 + 1 cm.
All the patients underwent oncologic and reconstruc-
tive procedures, carried out by a complete or
comprehensive oncoplastic breast surgeon (HF). In one
patient a reductive contralateral mammaplasty was per-
formed concomitantly to obtain symmetry. Table 2
shows pathologic features; surgical specimen volume
was calculated from specimen weight using the density
of 0.958 g/cm
3. Positive margins were defined as having
tumor cells right at the cut edge of the specimen. Close
margins were defined as having tumor cells between the
cut edge of the specimen and the boundary defined as
negative (>2 mm). All the patients in this series received
standard adjuvant radiotherapy, 50 Gy spread over four
weeks, adjuvant systemic chemotherapy and endocrine
therapy, which was indicated according to our standard
protocol based on clinical and pathological findings.
Minimum follow-up was 13 months with an average
of 58 from the date of initial pathological diagnosis until
the date of the last study follow-up. All patients were
followed-up clinically every 6 months for the first 3
years and then every year thereafter. Complete clinical
examination, bilateral mammograms, chest X-rays,
abdomino-pelvic ultrasonography and tumor markers
were performed in each revision. Bone scans were indi-
cated only in the event of suspicious blood tests or clini-
cal symptoms.
The end point analyzed was the status (alive or dead,
cause of death, free of disease or with recurrence, type
of recurrence and survival) at the date of the last follow-
up study.
Assessment of cosmetic outcome
Cosmetic outcome was evaluated by BCCT.core soft-
ware. Standardized digital front photographs were taken
of naked patients standing up straight with their arms
down beside the body after an average of 55 months
from the date of the end of radiotherapy. BCCT.core
(breast cancer conservative treatment cosmetic results)
software was developed by The University of Porto to
evaluate cosmetic results of BCT in an objective stan-
dardized semiautomatic way, and divides the result into
four categories (excellent, good, fair and bad) [9].
Patients were also asked about changes in the sensitiv-
ity of the nipple of the affected breast, chronic back
pain or functional limitations of the shoulder during
their domestic activities.
Statistical analysis
We calculated confidence intervals (CI) of proportion by
means of the Wilson method [12]. We study the corre-
lation between Vers and the actual volume excised.
Values of p < 0.05 were considered significant.
Results
Median follow-up was 58 months (13-95) and only two
patients were lost at 16 and 64 months into the follow-
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Page 2 of 7up. One patient developed an ipsilateral breast cancer
recurrence (2.4%), whose histological type was in situ
ductal carcinoma, diagnosed 32 months after the date of
the histological diagnosis. There were several factors
that could have influenced this oncologic outcome, such
as her young age (she was 44 years old), premenopausal
status, the specific characteristics of her tumor: negative
estrogen and progesterone receptors, positive Herb-2,
Table 1 Characteristics of 41 patients.
Characteristic Value IC-95%
Age (years)
Median (SD) 44 (7.5) 41.7 to 46.3
Range 22-58
Breast volume
a (cc)
Median (SD) 705.4 (294.0) 605.1 to 805.7
Patient with breast volume n, (%)
< 500 8 (24.2) 12.8 to 41.0
500-1000 22 (66.7)) 49.6 to 80.2
< 1000 3 (9.1) 3.1 to 23.6
NC 8
Size of tumor* (mm)
Median (SD) 22 (11.25) 18.4 to 25.6
Range 0-45
Estimated volume of resection ° (cc)
Median (SD) 47 (36.33) 35.3 to 58.7
Percentage of total breast volume
Median (SD) 8.5 (7.66) 5.8 to 11.3
Patients n, (percentage)
0-10% 21 (70) 52.1 to 83.3
10-20% 5 (16.7) 7.3 to 33.6
> 20% 4 (13.3) 5.3 to 29.7
NC 11
Distribution of tumor through the breast (no. patients)
Upper outer quadrant 19
Inferior inner quadrant 1
Inferior outer quadrant 3
Intersection upper quadrants 9
Intersection inferior quadrants 2
Intersection outer quadrants 4
Intersection inner quadrants 3
Multifocal
Yes 8 (19.5) 10.2 to 34.0
No 33 (80.5) 66.0 to 89.8
Histologic subtype of invasive carcinoma (no. of patients)
Ductal 27
Lobular 10
Solid 1
Apocrine 1
Phyllodes 1
Mixed 1
aVolume of the breast was calculated using the formula 1/3 pi H RccRol, (H) height and (Rol) radius measurements were taken from oblique mammogram
projection and Rcc radius from craneocaudal one.
* Tumor size was defined as the largest dimension recorded on mammogram or magnetic resonance imaging (MRI); in 19 patients who were treated
preoperatively with chemotherapy this measurement was taken from the MRI or mammogram once the treatment was finished or interrupted.
°Estimated volume of resection was determined using the formula 4/3 pi (tumor size/2 + 1)
3.
SD: standard deviation, CI: Confidence interval, NC: not confirmed
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Page 3 of 7and close margin caused by bifocal residual disease after
neoadjuvant chemotherapy with a microfoci separated
from the main tumor. She underwent a skin-sparing
mastectomy and immediate breast reconstruction with
an adjustable breast implant and she is alive and free of
disease after 63 months’ follow-up. (Figure 1)
Six patients developed distant metastases (14.63%), at
an average time of 30 months (19-46) after the date of
histological diagnosis, the metastases sites were: bone,
lung, liver and lymph nodes, and three patients died
(7.3%) due to the tumor without ipsilateral recurrence,
one of them presenting hepatic metastases at the time
of treatment. One patient developed a gastric cancer
and another was diagnosed with contralateral breast
cancer.
We were able to interview and evaluate 23 patients
cosmetically, the reasons for this being: three patients
died, one had an ipsilateral recurrence and was mastec-
tomized, three had a distant recurrence and were in a
bad state, one was diagnosed and treated for contralat-
eral breast cancer and one had a surgical procedure on
the affected breast, while the rest refused to participate
Table 2 Characteristics of the surgical specimen (breast tissue and axillary lymph nodes)
Characteristic Value IC 95%
Weight, g
Median (SD) 174.8 (70.9) 152.5 to 197.0
Range 42-381
Volume
a (cc)
Median (SD) 167.4 (67.9) 146.1 to 188.7
Range 40-364
Percentage of total breast volume
Median (SD) 24.7 (8.7) 21.6 to 27.8
Patients (IC)
0-10 0 0.0 to 11.0
10-20% 12 (38.7) 23.7 to 56.2
> 20% 19 (61.3) 43.8 t0 76.3
NC 10
Margin, patients (percentage)
Involved, tumors cells 0 17.6 to 44.5
Close,< 2 mm 12 (29.3) 55.5 to 82.4
Negative, no tumors cells 29 (70.7)
Minimal width of margin, mm
Median (SD) 5.2 (4.4) 3.8 to 6.6
Axillary lymph nodes
Number of patients with positive lymph nodes, n (percentage) 20 (52.6) 37.3 to 67.5
Number of patients with >3 positive lymph nodes n (percentage) 9 (23.7) 13.0 to 39.2
Positive hormone receptors, n (percentage)
Estrogenic 19 19.6 to 47.0
Progesterone 22
Herb-2 11
Triple-negative, n (percentage) 13 (31.7)
NC: not confirmed, CI: Confidence interval
Figure 1 Appearance of the patient who suffered from an
ipsilateral breast cancer recurrence, she underwent a skin-
sparing mastectomy and immediate breast reconstruction with
an adjustable breast implant. She did not want undergo a
reduction mammaplasty for simmetrization. Mammography showed
a small group of microcalcifications; the core biopsy confirmed an
in situ ductal carcinoma.
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evaluation results and the changes from the previous
evaluation [6,7]. In 19 patients we observed the evolu-
tion of the cosmetic outcomes, which had previously
been assessed subjectively by a mixed panel in 2005 or
2007; four of them (21.05%) have changed their assess-
ment deteriorating from good to fair.
No patients expressed functional limitation in activ-
ities of daily life and, it is worth commenting that three
women regularly go swimming, two or three times a
week. One expressed a decrease in nipple sensation and
another had chronic back pain.
Discussion
Breast surgery and, in particular, OBS should be an indi-
vidual process for each patient; the appropriate surgical
technique requires that the surgeon should choose
between the different options, weighing up the pros and
cons of each one. Multiple reconstructive techniques are
available for partial breast reconstruction, the dominant
criterion used for selection is the location of the tumor
but factors such as breast size, degree of ptosis and den-
sity of the breast tissue should be taken into account
[13]. The patient’s condition and preferences, character-
istics of the tumor [14], for example, associated compo-
nent in situ, lobular histologic type, and the level of the
surgeon’s expertise in OBS training also determine the
choice [15,16].
Reviewing articles about OBS, more specifically those
published in the last years, it can be observed that dis-
placement techniques are more frequently used than
volume replacement ones [17,18], one explanation
might be that some surgeons are reluctant to spend a
distant flap, such as LDF, for a partial breast reconstruc-
tion, concerned that this could potentially compromise
a reconstructive option in situations in which comple-
tion mastectomy is required. They prefer other options
like skin sparing mastectomy with immediate recon-
struction in those patients with small or medium breast
size where tumor excision causes large defects and
reshaping is not possible.
However, we consider that OVR are very useful when
the indication of radiotherapy postmastectomy is sure or
quite likely; in this situation, this option offers more
advantages than the skin sparing mastectomy with
immediate reconstruction. The procedure only requires
one surgical intervention, which takes less time, does
not need surgery on the contralateral breast and the
patients conserve their own nipples without changes in
sensation. In our series almost half of the patients had
had radiotherapy indication if a mastectomy was carried
out based on the initial size of the tumor or on the
lymph node status.
Although new OVR techniques based on artery per-
forator flaps [19] as thoracodorsal flaps [20] have gained
acceptance in the reconstruction options because they
could replace the classic LDF not sacrificing this muscle
and avoiding common donor site morbidity and post-
operative seroma, the LDF remains as preferential
option in some clinical situations as central or medial
defects in patients with small or moderate size breast
(bra cup size A,B,C) [21,22].
Outcomes of OBS are scarce and much more if we are
dealing with OVR. In 2007 and 2008 Asgeirsson KS and
Rainsbury [17,18] published a review of seven series
with a total of 189 patients with a follow-up of 24 to 53
months showing a low local recurrence rate (0 to 5%)
and cosmetic failure rate (0 to 18%); our work obtained
similar rates which fall into the range of this series but
adds some more information about one OVR, the partial
mastectomy with immediate LDF reconstruction, the
usefulness in all quadrants of the breast achieving accep-
table and stable aesthetic outcomes over a long period
of time (Figure 2).
Our series can be characterized with some data:
patients below the average age of breast cancer (44
years) with medium size breasts (705 cc average of total
b r e a s tv o l u m e )s u f f e r e df r o mt u m o r sw i t h2 2m mo f
average size (22 after neoadjuvant chemotherapy)
located in all quadrants of the breast, multifocal in 20%
cases, with high rate of axillary lymph node affectation
(46.3%) and triple-negative receptors (31.7%). The OVR
Table 3 Aesthetic results.
Method of Evaluation EXCELLENT GOOD FAIR BAD total
Panel, 2005 2 (6.8) 15 (51.7) 11 (37.9) 1 (3.4) 29
BCCT.core, 2010 3 (13.0) 12 (52.2) 8 (34.8) 0 23
n (percentage)
Figure 2 Long-term aesthetic results of OVR used in the four
quadrants of the breast.
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involved ones) and a good local control (rate of ipsila-
terall recurrence of 2.4%) but significant discordance
between the estimated volume of resection (6.6% of the
breast volume) and the actual volume excised (24.7%)
was observed (correlation coefficient, r = 0.0195, p =
0.321). The explanation for this is the surgical specimen,
a quadrantectomy or sector partial mastectomy, which
does not fit a sphere containing the tumor in the core
so some healthy breast tissue is unnecessarily taken out.
Despite the high breast volume excised, with an average
of 167 cc, which is similar to other published data (23,
24), the cosmetic results were not negatively affected.
Cosmetic outcome in OBS evaluated with an objective
method have not been published previously. Aesthetic
outcomes evaluated by BCCT.core are worse than when
they are evaluated by a panel [25], but this is an objec-
tive and easily reproducible method which offers us the
opportunity to standardize the evaluation allowing a fair
comparison between different studies.
Cosmetically satisfactory results were achieved in 65% of
cases after a long follow-up period 54 months (range from
5 to 92), similar results have been published by other
authors such as Naguib SF [26], who published 69% in a
series of 29 patients, in which LDF was used in 21 cases,
and 16 kept their NAP after a follow-up ranging from 3 to
36 months and Tomita K [27], who achieved 75% good
cosmetic results in 44 patients evaluated by a mixed panel
one year after the end of treatment.
In 19 patients we observed the evolution of the cos-
metic outcomes because they were assessed subjectively
by a mixed panel in 2005 or 2007. Only four patients
have changed their assessment with deterioration from
good to fair (Figure 3). The main reason that could
explain this worsening is the increment of the asym-
metry, which was together with the scar of the recon-
structed breast the main factor determining the
aesthetic result [6,28]. Like other breast surgeries
(reconstruction, reduction and augmentation),
changes in the weight status worsen the aesthetic
r e s u l t sa sw ec o u l ds e ei nt h r e eo ft h ef o u rp a t i e n t s
whose aesthetic results worsened, two having put on
weight and the other, who suffered from a second
neoplasia, an advanced gastric carcinoma, losing
weight dramatically.
Finally, we observed that the technique does not cause
al a t em o r b i d i t ya n dt h ep a t i e n t sh a v eac o m p l e t e
adjustment and do not have limitations in everyday life.
Conclusion
This OVR obtained a good local control and satisfactory
and stable aesthetic results which have maintained
unchanged after a long period of time. This option
should be considered when the postmastectomy radio-
therapy indication is present or likely
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